Literature DB >> 12902327

Protein-tyrosine phosphatase 1B mediates the effects of insulin on the actin cytoskeleton in immortalized fibroblasts.

Shrikrishna Dadke1, Jonathan Chernoff.   

Abstract

Insulin regulates diverse cellular responses including actin reorganization. The mechanism by which insulin induces formation of lamellipodia in cultured cells is not known but is likely to involve activation of Src family protein-tyrosine kinases. Here we show that protein-tyrosine phosphatase 1B (PTPIB) activates Src, thereby initiating the activation of a Rac-dependent pathway leading to cytoskeletal remodeling. Conversely, expression of a proline to alanine (P309,310A) PTP1B mutant, which cannot activate Src, fails to activate Rho GTPases or cause changes in actin organization. Rat fibroblasts lacking PTP1B expression do not activate Src or Rac in response to insulin and cannot reorganize actin. These results show that PTP1B, best known as a negative regulator of the metabolic effects of insulin, is required for the effects of insulin on actin organization in immortalized fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902327     DOI: 10.1074/jbc.M306772200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Protein tyrosine phosphatase 1B impairs diabetic wound healing through vascular endothelial growth factor receptor 2 dephosphorylation.

Authors:  Jing Zhang; Limin Li; Jing Li; Yuan Liu; Chen-Yu Zhang; Yujing Zhang; Ke Zen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-13       Impact factor: 8.311

2.  Investigation of protein-tyrosine phosphatase 1B function by quantitative proteomics.

Authors:  Philipp Mertins; H Christian Eberl; Jörg Renkawitz; Jesper V Olsen; Michel L Tremblay; Matthias Mann; Axel Ullrich; Henrik Daub
Journal:  Mol Cell Proteomics       Date:  2008-05-31       Impact factor: 5.911

Review 3.  PTP1B: a double agent in metabolism and oncogenesis.

Authors:  Shu-Chin Yip; Sayanti Saha; Jonathan Chernoff
Journal:  Trends Biochem Sci       Date:  2010-04-08       Impact factor: 13.807

4.  Caveolin-1 phosphorylation regulates vascular endothelial insulin uptake and is impaired by insulin resistance in rats.

Authors:  Hong Wang; Aileen X Wang; Kevin Aylor; Eugene J Barrett
Journal:  Diabetologia       Date:  2015-03-10       Impact factor: 10.122

5.  Protection against LPS-induced pulmonary edema through the attenuation of protein tyrosine phosphatase-1B oxidation.

Authors:  Katie L Grinnell; Havovi Chichger; Julie Braza; Huetran Duong; Elizabeth O Harrington
Journal:  Am J Respir Cell Mol Biol       Date:  2011-12-28       Impact factor: 6.914

6.  Inhibition of protein-tyrosine phosphatase 1B (PTP1B) mediates ubiquitination and degradation of Bcr-Abl protein.

Authors:  Daniel Alvira; Ruth Naughton; Lavinia Bhatt; Sara Tedesco; William D Landry; Thomas G Cotter
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

7.  The nucleus- and endoplasmic reticulum-targeted forms of protein tyrosine phosphatase 61F regulate Drosophila growth, life span, and fecundity.

Authors:  Bree J Buszard; Travis K Johnson; Tzu-Ching Meng; Richard Burke; Coral G Warr; Tony Tiganis
Journal:  Mol Cell Biol       Date:  2013-01-22       Impact factor: 4.272

Review 8.  Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability.

Authors:  Matthew R DiStasi; Klaus Ley
Journal:  Trends Immunol       Date:  2009-09-23       Impact factor: 16.687

Review 9.  Protein tyrosine phosphatases: structure, function, and implication in human disease.

Authors:  Lutz Tautz; David A Critton; Stefan Grotegut
Journal:  Methods Mol Biol       Date:  2013

10.  Activation of Src by protein tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells.

Authors:  Luis E Arias-Romero; Sayanti Saha; Olga Villamar-Cruz; Shu-Chin Yip; Stephen P Ethier; Zhong-Yin Zhang; Jonathan Chernoff
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.